Physician profile
Paul E Kramer
NPI 1790794048
$5,072.17
in general payments reported to CMS, 2019-2025
32 companies · $848 in 2025
The $848 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $553 · 2021: $816 · 2022: $733 · 2023: $827 · 2024: $634 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.29 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $712.71 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $653.71 | 2021-2025 | |
| Lilly USA, LLC | $632.27 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $608.01 | 2019-2025 | |
| Novo Nordisk INC | $365.99 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $337.74 | 2019-2023 | |
| Amgen INC. | $234.50 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $227.84 | 2019-2025 | Trintellix |
| Exact Sciences Corporation | $173.17 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $150.89 | 2022-2025 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.30 | 2021-2025 | Jardiance |
| Allergan, INC. | $99.04 | 2019-2020 | |
| Amarin Pharma, INC. | $77.05 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.96 | 2022 | |
| Phathom Pharmaceuticals, INC. | $57.65 | 2024-2025 | Voquezna |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.74 | 2022 | |
| Merck Sharp & Dohme LLC | $55.54 | 2021-2023 | Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $46.72 | 2022-2025 | |
| Biodelivery Sciences International, INC. | $45.39 | 2019-2020 | |
| Antares Pharma, INC. | $40.55 | 2024-2025 | Xyosted |
| Teva Pharmaceuticals USA, INC. | $35.18 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $30.46 | 2025 | Rexulti |
| Eisai INC. | $30.05 | 2021 | |
| Azurity Pharmaceuticals, INC. | $27.56 | 2024 | Horizant |
| Vertex Pharmaceuticals Incorporated | $27.55 | 2025 | |
| Novartis Pharmaceuticals Corporation | $25.13 | 2024 | |
| Almatica Pharma LLC | $24.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.38 | 2019 | |
| Abbott Laboratories | $20.33 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.33 | 2021 | |
| Acerus Pharmaceuticals Corporation | $14.87 | 2021 | |
| Tolmar, INC. | $14.09 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.